Tag: future

Posts with tag: future

Latest Posts

Mexico, U.S. agree on 'open dialogue' over tariffs, trade pact

Mexican and U.S. officials agree to discuss economic issues including supply chains and foreign investment, while the USMCA revision is set for 2026.

Trump Tariffs Aim to Revive U.S. Manufacturing, Treasury Secretary Says

Trump's tariffs target manufacturing, Treasury Secretary says

Workday Cuts 8.5% of Workforce, Joining Tech Giants in Headcount Reductions

Workday cuts 8.5% of workforce, focusing on strategic areas like AI and overseas expansion.

Big Tech AI Spending Hits $228 Billion as DeepSeek Raises Questions

Meta, Microsoft, Google, and Amazon are expected to spend a combined $228 billion on AI infrastructure in 2025, a 55% increase from 2024. Investors are concerned about the timeline for the payoff and whether such high levels of spending are justified, especially in light of the recent debut of DeepSeek, a Chinese startup that offers competitive AI models at a fraction of the price. Despite these concerns, Meta, Microsoft, and Google have all announced plans to increase their AI spending in 2025, while Amazon is expected to report its AI spending plans when it reports fourth quarter earnings on Thursday.

Novo Nordisk Not Too Concerned About Medicare Price Negotiations

Novo Nordisk CEO is unconcerned about Medicare drug price negotiations due to comparable prices in Europe, previous experience, and the company's focus on a strong pipeline and next-generation drugs.

Match Group Shares Tumble 10% on Weak Q4 Results and Missed Guidance

Match Group shares plunge 10.2% premarket after weak Q4 results and missed guidance, casting doubt on management's ability to stabilize demand and subscriber trends.

Workday (WDAY) Stock Jumps 6.5%: What Investors Should Consider

Workday (WDAY) stock surges 6.5% premarket on strong Q4 guidance and restructuring plans. Read our full analysis report for insights on the market's reaction and the stock's potential.

Novo Nordisk Beats Wall Street Expectations, Stock Surges

Novo Nordisk's Q4 earnings beat expectations, with key semaglutide drugs driving growth. Despite expected slower growth in 2025, the company remains optimistic and is addressing headwinds like drug pricing negotiations and supply chain issues.

Wall Street's Top Research Calls: AMD, Spotify Downgraded

Top analysts downgrade AMD and Spotify; Robinhood, CoStar, and Opera initiated

Tech Slumps on Concerns Over AI Investment Returns

Stocks dropped as underwhelming results from Alphabet Inc. and Advanced Micro Devices Inc. revived concerns about when the tech industry's AI spending will pay off.